Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W John

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The American Journal of Physiology|February 1, 1995
TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the ratF Bertolino, J P Valentin, M Maffre, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Attenuation by R 56865, a novel cytoprotective drug, of regional myocardial ischemia- and reperfusion-induced electrocardiographic disturbances in anesthetized rabbitsY Verscheure, G Pouget, F De Courtois, et al.
British Journal of Pharmacology|May 1, 1994
Prevention by specific chemical classes of alpha 1-adrenoceptor antagonists of veratrine-contractures in rat left atria independently of alpha 1-adrenoceptor blockadeB Le Grand, A Marty, B Vié, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 2, 2001
Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular systemR Létienne, B Vié, A Puech, et al.
American Journal of Hypertension|November 5, 1997
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the ratJ P Valentin, B Jover, M Maffre, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1994
[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog]F Bertolino, J P Valentin, M Maffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonistF Bertolino, J P Valentin, M Maffre, et al.
Cardiovascular Research|November 1, 1995
Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbitB Le Grand, B Vié, P Fauré, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 24, 1998
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest ratF Bertolino, J P Valentin, J F Patoiseau, et al.
Journal of Cardiovascular Pharmacology|November 1, 1995
Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potentialB Le Grand, J M Talmant, J P Rieu, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The American Journal of Physiology|February 1, 1995
TxA2 receptor activation elicits organ-specific increases in microvascular permeability in the ratF Bertolino, J P Valentin, M Maffre, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Attenuation by R 56865, a novel cytoprotective drug, of regional myocardial ischemia- and reperfusion-induced electrocardiographic disturbances in anesthetized rabbitsY Verscheure, G Pouget, F De Courtois, et al.
British Journal of Pharmacology|May 1, 1994
Prevention by specific chemical classes of alpha 1-adrenoceptor antagonists of veratrine-contractures in rat left atria independently of alpha 1-adrenoceptor blockadeB Le Grand, A Marty, B Vié, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 2, 2001
Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular systemR Létienne, B Vié, A Puech, et al.
American Journal of Hypertension|November 5, 1997
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the ratJ P Valentin, B Jover, M Maffre, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1994
[Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog]F Bertolino, J P Valentin, M Maffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonistF Bertolino, J P Valentin, M Maffre, et al.
Cardiovascular Research|November 1, 1995
Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbitB Le Grand, B Vié, P Fauré, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 24, 1998
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest ratF Bertolino, J P Valentin, J F Patoiseau, et al.
Journal of Cardiovascular Pharmacology|November 1, 1995
Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potentialB Le Grand, J M Talmant, J P Rieu, et al.
Pageof 5